Buy Flmodafinil (CRL-40,940)
€ 31.78 – € 107.38Price range: € 31.78 through € 107.38
Flmodafinil (CRL-40,940) is a potent fluorinated modafinil analog used in research on wakefulness, cognitive enhancement, and dopamine transporter inhibition.
Flmodafinil (CRL-40,940) Product Description
Introduction
Flmodafinil, also known as CRL-40,940, bisfluoromodafinil, or lauflumide, is a potent eugeroic (wakefulness-promoting agent) and nootropic compound. It is a fluorinated analog of modafinil, featuring two fluorine atoms substituted on its phenyl rings. Flmodafinil is designed to enhance cognitive function, wakefulness, and motivation, with claimed improved potency, metabolic stability, and fewer side effects compared to modafinil. It is typically a white to off-white crystalline powder used in pharmaceutical research and preclinical studies.
Chemical Properties and Specifications
2.1 Structural and Molecular Characteristics
-
Chemical Formula: C15H13F2NO2S
-
Molecular Weight: 309.33 g/mol
-
CAS Number: 90280-13-0
-
IUPAC Name: 2-(bis(4-fluorophenyl)methyl)sulfinylacetamide
-
Synonyms: Flmodafinil, CRL-40,940, bisfluoromodafinil, lauflumide
2.2 Physical Properties and Purity Standards
-
Appearance: White to off-white crystalline powder
-
Melting Point: 78-80°C
-
Boiling Point: 558.7 ± 50.0°C (predicted)
-
Density: 1.397 ± 0.06 g/cm³ (predicted)
-
Purity: Typically ≥99% pharmaceutical/research grade
-
Solubility: Highly soluble in DMSO (~100 mg/mL); soluble in polar organic solvents
-
Storage Recommendations: Store at -20°C in airtight containers, protected from moisture and light
Pharmacological Profile and Mechanism of Action
3.1 Proposed Mechanism of Action
Flmodafinil acts primarily by inhibiting dopamine reuptake transporters (DAT), increasing extracellular dopamine concentrations. It also influences other neurotransmitter systems to promote wakefulness and cognitive enhancement. Flmodafinil’s fluorinated structure enhances metabolic stability and blood-brain barrier penetration, contributing to improved potency and duration of action compared to modafinil.
3.2 Research Applications
Flmodafinil is widely applied in pharmacological and neuroscientific studies evaluating wakefulness-promoting mechanisms, cognitive enhancement, and dopamine transporter modulation. It is of significant interest for therapeutic research in conditions like chronic fatigue syndrome, idiopathic hypersomnia, and attention deficit hyperactivity disorder (ADHD).
Comparative Analysis with Related Compounds
4.1 Comparison with Related Compounds
Flmodafinil differs from modafinil by adding two fluorine atoms on the phenyl rings, which increases potency and metabolic resistance. Compared to armodafinil and esmodafinil, it offers different enantiomeric profiles and potentially longer-lasting effects. Flmodafinil has demonstrated enhanced efficacy and fewer side effects in preliminary studies.
4.2 Advantages for Research
Its high purity and solubility support reproducible dosing and formulation. Enhanced blood-brain barrier penetration and metabolic stability make it valuable for cognitive and wakefulness studies. The compound’s clinical trial status offers translational research potential.
Safety and Handling Guidelines
5.1 Laboratory Safety
Use gloves, protective eyewear, and lab coats when handling Flmodafinil powder. Perform work in well-ventilated environments or fume hoods. Avoid inhalation, ingestion, and skin contact.
5.2 Disposal and Environmental Considerations
Dispose of according to institutional hazardous chemical regulations. Prevent environmental contamination.
5.3 Regulatory Status
Flmodafinil is a research chemical with investigational drug status. It is not approved for general medical use and is subject to regulatory controls in various regions. Adherence to all applicable laws and research guidelines is mandatory.
Frequently Asked Questions (FAQs)
-
What is the molecular formula of Flmodafinil?
C15H13F2NO2S. -
What is the CAS number for Flmodafinil?
90280-13-0. -
How soluble is Flmodafinil?
Highly soluble in DMSO (~100 mg/mL); soluble in polar organic solvents. -
What pharmacological effects does Flmodafinil produce?
Wakefulness promotion, cognitive enhancement, dopamine transporter inhibition. -
What are typical research applications of Flmodafinil?
Neuropharmacology, wakefulness studies, ADHD research, cognitive enhancement.
Conclusion
Flmodafinil (CRL-40,940) is a high-potency, fluorinated modafinil analog that promotes wakefulness and cognitive enhancement through dopamine transporter inhibition. Its enhanced stability and efficacy profile make it a valuable compound in pharmaceutical and neuroscience research.
| Quantity |
2g ,5g ,10g |
|---|
Related products
Buy Coluracetam
Coluracetam is a high-purity racetam nootropic enhancing cognitive function via cholinergic system modulation.
Buy Emoxypine Succinate
Emoxypine succinate is a water-soluble antioxidant research chemical used to study neuroprotection, oxidative stress, and mitochondrial health in laboratory models.
Buy F-Phenibut HCL
F-Phenibut HCL is a white crystalline fluorinated GABA-B receptor agonist salt used in research on inhibitory neurotransmission and anxiolytic effects.
Buy Fasoracetam
Fasoracetam is a white crystalline nootropic racetam research chemical targeting metabotropic glutamate receptors for cognitive and anxiolytic studies.
Buy HA-966 HCl
HA-966 HCl is a racemic NMDA receptor glycine site antagonist used in neuroprotective and anxiolytic research.
Buy NSI-189 Free Base
NSI-189 Free Base is a crystalline neurogenic compound used in research to stimulate hippocampal neurogenesis and cognitive enhancement. It is highly pure and stored under cool conditions.
Buy Phenylpiracetam
Phenylpiracetam is a racetam nootropic enhancing cognition and physical performance. It is a white crystalline research compound with high bioavailability.
Fladrafinil – CRL-40,941
Fladrafinil (CRL-40,941) is a bis(4-fluorophenyl)-substituted eugeroic research chemical with wakefulness-promoting and anti-aggressive properties, used for neuropharmacological research.

Reviews
There are no reviews yet.